update
Sanofi Starts Semisynthetic Malaria Drug Production
Sanofi has started making artemisinin using a novel semisynthetic method it says will strengthen the global supplies of malaria drugs.
Archives for April 16, 2013
US FDA to Require Abuse-Deterrent Formulations for OxyContin Generics
One day after Purdue Pharma’s blockbuster opioid OxyContin lost its first patent, the US FDA has amended the drug’s label and now requires generic drugmakers to adopt similar abuse-deterrent formulations.
Chinese Drugmakers Still Suffering from Chromium Capsule Scandal
Biostar Pharmaceuticals has blamed end-of-year losses on last year’s chromium-tainted gelatin scandal though it is slowly recovering following a suspension of sales enforced by the SFDA.
MSD Pushes Emerging Market Strategy With New China Packaging Facility
Merck & Co. has opened a new packaging facility in China to support its emerging market strategy but says it is still committed to traditional regions.
InVentiv Pushes into Highly Sought-After Japanese Market with Collaboration
CRO inVentiv Health has expanded its international presence through a partnership with one of the largest Japenese CROs, Bell Medical Solutions.
DHL: Globalisation, Generics & Biologics Drive Cold Chain Expansion
Globalisation, outsourcing and a move towards biopharmaceuticals are leading innovation for pharma distribution companies, according to DHL Global Forwarding.
DKSH Bags Pfizer Deal in Cambodia
DKSH has won a second deal with a Big Pharma firmin Asia in as many months, with US giant Pfizer signing up the firm as its agent in Cambodia.